10 Agent-based cell modeling: application to breast cancer1 With P. Macklin and M.E. Edgerton In Chapter 6, we discussed an agent-based cell model that can be applied to a variety of biological systems, with a particular

First Page		Document Content
Date: 2013-12-07 13:45:20 Mammary ductal carcinoma CDH1 Lobular carcinoma in situ Lumpectomy Atypical ductal hyperplasia Cell culture Epithelium Carcinogenesis Radiation therapy Medicine Biology Breast cancer		10 Agent-based cell modeling: application to breast cancer1 With P. Macklin and M.E. Edgerton In Chapter 6, we discussed an agent-based cell model that can be applied to a variety of biological systems, with a particular Add to Reading List Source URL: www.mathcancer.org Download Document from Source Website File Size: 1,94 MB Share Document on Facebook

	CONTENT SPECIFICATIONS ARRT BOARD APPROVED: JANUARY 2015 IMPLEMENTATION DATE: JULYThe Mammography DocID: 1b22b - View Document
	$1,000,0000 SETTLEMENT IN BREAST CANCER MISDIAGNOSIS CASE. Medical Malpractice Trial Report BREAST CANCER Medical Malpractice Lawsuit:   Delay in Diagnosis of Breast Cancer Worsens Prognosis. At a routine office visit DocID: 1aKXQ - View Document
	Changing trends in breast fine-needle aspiration: Results of the Papanicolaou society of cytopathology survey DocID: 18uZy - View Document
	AIFA-UNICRI- OPBG-NIMR Training Course “Good Clinical Practices (GCP) in developing settings: the promotion of international harmonization for the respect of ethical principles, human DocID: 17GTW - View Document
	Basic ductal carcinoma in situ (DCIS) pathobiology for modelers Paul Macklin∗ † Center for Applied Molecular Medicine Keck School of Medicine University of Southern California DocID: 14Eb7 - View Document